SPC for ezetimibe/simvastatin considered invalid in preliminary relief proceedings
Targeted treatments – Part 3: the power of orphan drug protection
par Dr Paul England
German Federal Court of Justice invalidates Truvada SPC
Targeted treatments – Part 1: Targeted treatments: patents for particular populations
par Dr Paul England
CJEU ruling to liberalise parallel import in Poland
Biologics and biosimilars litigation update
Return to work: key issues for life sciences
par Helen Farr et Adrian Toutoungi
Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
par plusieurs auteurs
4 de 6 Publications
Licensing out: Try not to get benched
par Colin McCall et Justyna Ostrowska
Conférences et Webinars
Retrouvez les analyses de nos experts sur les dernières questions juridiques.
Voir tous les évènements
SPC for ezetimibe/simvastatin considered invalid in preliminary relief proceedings
Targeted treatments – Part 3: the power of orphan drug protection
par Dr Paul England
German Federal Court of Justice invalidates Truvada SPC
Targeted treatments – Part 1: Targeted treatments: patents for particular populations
par Dr Paul England
CJEU ruling to liberalise parallel import in Poland
Biologics and biosimilars litigation update
Return to work: key issues for life sciences
par Helen Farr et Adrian Toutoungi
Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
par plusieurs auteurs
4 de 6 Publications
Licensing out: Try not to get benched
par Colin McCall et Justyna Ostrowska